- One of the world’s most prescribed cholesterol-lowering drugs, atorvastatin, has come under scrutiny after the US Food and Drug Administration (FDA) issued a Class II recall affecting over 142,000 bottles distributed by Ascend Laboratories. The move has raised safety concerns globally, as millions depend on atorvastatin to manage high cholesterol and prevent cardiovascular diseases.
 
 
                                        Month: Current Affairs - November 03, 2025
                                        Category: global regulatory